Charles River Laboratories reported $3.7M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amerisourcebergen ABC:US $ 57.66M 2.28M
Anthem ANTM:US $ 208M 7M
Bio Rad Laboratories BIO:US $ 10.72M 6.67M
Cardinal Health CAH:US 34M 4M
Catalent CTLT:US $ 33M 1M
Charles River Laboratories CRL:US $ 3.7M 5.73M
Cigna CI:US $ 301M 2M
CVS Health CVS:US $ 583M 3M
Danaher DHR:US $ 51M 3M
Hologic HOLX:US $ 22.7M 0.1M
Humana HUM:US $ 101M 11M
Illumina ILMN:US $ 6M 0M
IQVIA Holdings Inc IQV:US $ 94M 8M
Laboratory Of America LH:US $ 42.5M 0.3M
Lonza Group LONN:SW 28M 2M
Mckesson MCK:US $ 45M 2M
Mettler Toledo International MTD:US 12.76M 1.43M
Novartis NOVN:VX 202M 1000K
Perkinelmer PKI:US $ 27.13M 1.26M
Pfizer PFE:US $ 293M 29M
Thermo Fisher Scientific TMO:US $ 148M 12M
United Therapeutics UTHR:US $ 6.2M 1.5M
UnitedHealth UNH:US $ 467M 34M
Waters WAT:US $ 8.89M 2.17M
West Pharmaceutical Services WST:US $ 1.8M 0.4M
YTE INCY:US $ 0.68M 0M